Investment in human capital

Pfizer's investment in Thessaloniki is mainly an investment in human capital, says Nico Gariboldi, senior director at the pharmaceutical company's Global Digital and Technology Hub. Speaking to Kathimerini, he describes the timetable of the American pharmaceutical corporation's investment in the northern Greek city and the profile of scientists currently staffing the digital hub.

"We are very close to reaching the target of 200 employees," Gariboldi notes, stressing that the people who make up the personnel of the Thessaloniki hub are employed in sectors of high expertise, with several having specialized in domains such as information technology.

By tapping the endless potential of digital technology, the hub's team is focusing on the digitalization of the sector of drug research and development, while also planning to develop synergies with universities, research...

Continue reading on: